News & Updates

Obesity, diabetes, family history up prostate cancer risk in IBD patients
Obesity, diabetes, family history up prostate cancer risk in IBD patients
10 Feb 2022 byStephen Padilla

A longitudinal national database study of patients with inflammatory bowel disease (IBD) has identified several risk factors for the development of prostate cancer (PC), including age, obesity, diabetes, married status, family history of PC, and African American race.

Obesity, diabetes, family history up prostate cancer risk in IBD patients
10 Feb 2022
Waist-height ratio predicts severe diabetic eye disease risk in T1D
Waist-height ratio predicts severe diabetic eye disease risk in T1D
08 Feb 2022 byStephen Padilla

Waist-height ratio (WHtR), a hallmark of central obesity, appears to be a good indicator for the risk of developing severe diabetic eye disease (SDED) in adults with type 1 diabetes (T1D), results of a 15-year cohort study suggest.

Waist-height ratio predicts severe diabetic eye disease risk in T1D
08 Feb 2022
Systemic inflammation mediates obesity-related severe COVID-19
Systemic inflammation mediates obesity-related severe COVID-19
04 Feb 2022 byStephen Padilla

Systemic inflammation plays a significant role in severe COVID-19 associated with obesity, particularly in patients aged <65 years, as captured by peak C-reactive protein (CRP) levels and erythrocyte sedimentation rate (ESR), a study has found.

Systemic inflammation mediates obesity-related severe COVID-19
04 Feb 2022
Tirzepatide regulates metabolites, lipids in T2D
Tirzepatide regulates metabolites, lipids in T2D
02 Feb 2022

Treatment with tirzepatide leads to a reduction in body weight and improvement in glycaemic control in individuals with type 2 diabetes (T2D), reports a study. In addition, it modulates metabolites associated with T2D risk and metabolic dysregulation that is consistent with improved metabolic health.

Tirzepatide regulates metabolites, lipids in T2D
02 Feb 2022